Ardian , developer of a device that could help treat high blood pressure, has brought in $47 million in a third round of funding led by Medtronic and including Emergent Medical Partners , Advanced Technology Ventures , Morgenthaler Ventures and Split Rock Partners .

Based in Palo Alto, the company claims that its technology relieves hypertension and risk of coronary disease or stroke to a greater degree than drug treatments like ACE inhibitors and beta blockers.

Ardian has raised $66 million to date.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.